FdaApplication
BLA 203314
Identifiers
- fda_app_no: BLA203314
Properties
| Property | Value |
|---|---|
| applicant_name | Novo Nordisk Inc. |
| application_type | BLA |
| approval_date | 2015-09-25 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TRESIBA | INSULIN DEGLUDEC | 300UNITS/3ML (100UNITS/ML) | Injection |
| TRESIBA | INSULIN DEGLUDEC | 1,000UNITS/10ML (100UNITS/ML) | Injection |
| TRESIBA | INSULIN DEGLUDEC | 600UNITS/3ML (200UNITS/ML) | Injection |
3 products